MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will showcase several recent developments in next-generation AI solutions at the 109 th Scientific Assembly and Annual Meeting of the ...
Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care The transaction supports Hologic’s strategy to provide a comprehensive suite of ...
Rising incidence of breast cancer, growing adoption of breast-conserving surgeries, and increasing demand for minimally invasive and radiation-free localization technologies are the major factors ...
Over the years, Hologic’s HOLX Breast Health business has evolved, shifting from a heavily capital-focused approach to generating higher recurring revenues. While service revenues now exceed capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results